Hyoscyamine Market Grows with GI and Urinary Disorder Demand
  United States of America – The Hyoscyamine Market is expected to register a CAGR of 4.3% from 2025 to 2031. The report forecasts steady growth driven by increasing demand for hyoscyamine-based therapies targeting gastrointestinal (GI) and urinary disorders, including irritable bowel syndrome (IBS), peptic ulcers, and urinary tract spasms. According to the Hyoscyamine Market...
0 Comments 0 Shares 642 Views 0 Reviews
MTSocial https://mtsocial.ir